Overview
Updated 14 Jul 2026
Mark Litzow, M.D., is Professor of Medicine, Division of Hematology, Mayo Clinic (Rochester, MN). The public record shows 1,323 publications with 48,382 citations (h-index 106), centered on Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 9 companies, 1 NIH-funded awards (2001–2003).
- Most recent indexed publication: 2026 · Blood advances
- Top research focus: Acute Myeloid Leukemia Research
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 156 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 507.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 3Active, not recruitingNCT02003222 - Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)
Sponsor: Mayo Clinic
InvestigatorWithdrawnNCT01569373 - Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer
Sponsor: Mayo Clinic
InvestigatorPhase 1CompletedNCT00652691
Industry payments
Updated 14 Jul 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202511 payments$38,915openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2001–2003 per NIH RePORTER. The latest:
- DENDRITIC CELL THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA
Mayo Clinic Coll of Medicine, Rochester
FY2003$283,392R01CA084368 - DENDRITIC CELL THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA
Mayo Clinic Coll of Medicine, Rochester
FY2002$385,731R01CA084368 - DENDRITIC CELL THERAPY OF CHRONIC MYELOGENOUS LEUKEMIA
Mayo Clinic Coll of Medicine, Rochester
FY2001$374,591R01CA084368
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia.
Science signaling
2026
Most-cited worksby citation count (OpenAlex)
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- Fellowship
Hematology and Medical Oncology, Mayo Clinic College of Medicine and Science (Rochester), 1986-1989 (NOTE: fresh-pass input listed this as "completed 1990" sourced to Healthgrades …
1990verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
- Board Certified
American Board of Internal Medicine: Internal Medicine, Hematology, Medical Oncology, and Hospice and Palliative Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Editorial & leadership rolesjournal and society appointments
- Former Chair
Leukemia Committee, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) -- chaired 2013-2022, succeeded by Selina M. Luger, MD as of December 2022 (PAST role …
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog-ecog-acrin.org ↗ - Former Director
Blood and Marrow Transplant (BMT) Program, Mayo Clinic (1992-2008); remains actively involved in the BMT program in an unspecified capacity (PAST directorship, ongoing informal involvement)
2008verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bmtinfonet.org ↗ - Head
Acute Leukemia and Myeloid Neoplasm Group / Acute Leukemia Group, Division of Hematology, Mayo Clinic (current)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.elsevierpure.com ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →intheloop.mayoclinic.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →intheloop.mayoclinic.org ↗
- YouTube interview series (OncLive/Targeted Oncology producer): "Personalized Leukemia Treatment For Older Adults With ALL"
"How Genomic Risk And Immunotherapy Shape ALL Treatment" …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/mark-litzow-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/mark-litzow-7a844a15b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/mark-litzow-a9021319a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Instagram
instagram.com/p/DQxvHCmDIhy
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
vjhemonc.com/speaker/mark-litzow
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ayalew Tefferi, MD
Mayo Clinic
- 2,093
- publications
- 154
- h-index
- 7
- trials
Angela Dispenzieri, MD
Mayo Clinic
- 2,490
- publications
- 146
- h-index
- 13
- trials
Shaji Kumar, MD
Mayo Clinic
- 2,207
- publications
- 137
- h-index
- 39
- trials
Morie Gertz, MD
Mayo Clinic
- 1,944
- publications
- 140
- h-index
- 7
- trials